About Corporacio Sanitaria Parc Tauli; Servicio de Oncologia
El Hospital de Sabadell, también conocido como Hospital Taulí u Hospital Parc Taulí, es el principal hospital de la ciudad de Sabadell. Se encuentra en el parque Taulí, en la parte nordeste de la ciudad, conocida como el Taulí.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
32
Genentech, Inc.
1
Puma Biotechnology, Inc.
1
Clinical Trials at Corporacio Sanitaria Parc Tauli; Servicio de Oncologia
During the past decade, Corporacio Sanitaria Parc Tauli; Servicio de Oncologia conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 20 clinical trials were completed, i.e. on
average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.
2006-06-26
2014-09-22
Completed
417
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
2009-02-04
2018-06-03
Completed
233
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
2007-08-30
2016-05-31
Completed
3,942
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy
2012-01-11
2022-08-31
Completed
273
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Corporacio Sanitaria Parc Tauli; Servicio de Oncologia"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Corporacio Sanitaria Parc Tauli; Servicio de Oncologia
According to Clinical.Site data, the most researched conditions in "Corporacio Sanitaria Parc Tauli; Servicio de Oncologia" are
"Breast Cancer" (8 trials), "Breast Neoplasms" (3 trials), "Ovarian Cancer" (3 trials), "Non-Small Cell Lung Cancer" (2 trials) and "Urothelial Carcinoma" (2 trials). Many other conditions were trialed in "Corporacio Sanitaria Parc Tauli; Servicio de Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Corporacio Sanitaria Parc Tauli; Servicio de Oncologia
Most popular intervention types in "Corporacio Sanitaria Parc Tauli; Servicio de Oncologia" are "Drug" (33 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (14 trials), "Carboplatin" (9 trials), "Placebo" (9 trials), "Paclitaxel" (8 trials) and "Docetaxel" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Corporacio Sanitaria Parc Tauli; Servicio de Oncologia
The vast majority of trials in "Corporacio Sanitaria Parc Tauli; Servicio de Oncologia" are
26 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Corporacio Sanitaria Parc Tauli; Servicio de Oncologia
Currently, there are NaN active trials in "Corporacio Sanitaria Parc Tauli; Servicio de Oncologia".
undefined are not yet recruiting,
5 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Corporacio Sanitaria Parc Tauli; Servicio de Oncologia,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Corporacio Sanitaria Parc Tauli; Servicio de Oncologia, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 25 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".